Abstract

Senescent cells accumulate in fat with aging. We previously found genetic clearance of senescent cells from progeroid INK-ATTAC mice prevents lipodystrophy. Here we show that primary human senescent fat progenitors secrete activin A and directly inhibit adipogenesis in non-senescent progenitors. Blocking activin A partially restored lipid accumulation and expression of key adipogenic markers in differentiating progenitors exposed to senescent cells. Mouse fat tissue activin A increased with aging. Clearing senescent cells from 18-month-old naturally-aged INK-ATTAC mice reduced circulating activin A, blunted fat loss, and enhanced adipogenic transcription factor expression within 3 weeks. JAK inhibitor suppressed senescent cell activin A production and blunted senescent cell-mediated inhibition of adipogenesis. Eight weeks-treatment with ruxolitinib, an FDA-approved JAK1/2 inhibitor, reduced circulating activin A, preserved fat mass, reduced lipotoxicity, and increased insulin sensitivity in 22-month-old mice. Our study indicates targeting senescent cells or their products may alleviate age-related dysfunction of progenitors, adipose tissue, and metabolism.

Article and author information

Author details

  1. Ming Xu

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  2. Allyson K Palmer

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    Allyson K Palmer, This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies.
  3. Husheng Ding

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  4. Megan M Weivoda

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  5. Tamar Pirtskhalava

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    Tamar Pirtskhalava, This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies.
  6. Thomas A White

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  7. Anna Sepe

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  8. Kurt O Johnson

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  9. Michael B Stout

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  10. Nino Giorgadze

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    Nino Giorgadze, This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies.
  11. Michael D Jensen

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  12. Nathan K LeBrasseur

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    No competing interests declared.
  13. Tamar Tchkonia

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    Competing interests
    Tamar Tchkonia, This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies.
  14. James L Kirkland

    Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, United States
    For correspondence
    Kirkland.James@mayo.edu
    Competing interests
    James L Kirkland, This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies.

Ethics

Animal experimentation: Experimental procedures (A21013, A37715 and A16315) were approved by the IACUC at Mayo Clinic

Human subjects: The protocol (10-005236) was approved by the Mayo Clinic Foundation Institutional Review Board for Human Research. Informed consent and consent to publish was obtained from all human subjects.

Copyright

© 2015, Xu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 10,247
    views
  • 2,396
    downloads
  • 452
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ming Xu
  2. Allyson K Palmer
  3. Husheng Ding
  4. Megan M Weivoda
  5. Tamar Pirtskhalava
  6. Thomas A White
  7. Anna Sepe
  8. Kurt O Johnson
  9. Michael B Stout
  10. Nino Giorgadze
  11. Michael D Jensen
  12. Nathan K LeBrasseur
  13. Tamar Tchkonia
  14. James L Kirkland
(2015)
Targeting senescent cells enhances adipogenesis and metabolic function in old age
eLife 4:e12997.
https://doi.org/10.7554/eLife.12997

Share this article

https://doi.org/10.7554/eLife.12997

Further reading

    1. Developmental Biology
    Shannon H Carroll, Sogand Schafer ... Eric C Liao
    Research Article

    Wnt signaling plays crucial roles in embryonic patterning including the regulation of convergent extension (CE) during gastrulation, the establishment of the dorsal axis, and later, craniofacial morphogenesis. Further, Wnt signaling is a crucial regulator of craniofacial morphogenesis. The adapter proteins Dact1 and Dact2 modulate the Wnt signaling pathway through binding to Disheveled. However, the distinct relative functions of Dact1 and Dact2 during embryogenesis remain unclear. We found that dact1 and dact2 genes have dynamic spatiotemporal expression domains that are reciprocal to one another suggesting distinct functions during zebrafish embryogenesis. Both dact1 and dact2 contribute to axis extension, with compound mutants exhibiting a similar CE defect and craniofacial phenotype to the wnt11f2 mutant. Utilizing single-cell RNAseq and an established noncanonical Wnt pathway mutant with a shortened axis (gpc4), we identified dact1/2-specific roles during early development. Comparative whole transcriptome analysis between wildtype and gpc4 and wildtype and dact1/2 compound mutants revealed a novel role for dact1/2 in regulating the mRNA expression of the classical calpain capn8. Overexpression of capn8 phenocopies dact1/2 craniofacial dysmorphology. These results identify a previously unappreciated role of capn8 and calcium-dependent proteolysis during embryogenesis. Taken together, our findings highlight the distinct and overlapping roles of dact1 and dact2 in embryonic craniofacial development, providing new insights into the multifaceted regulation of Wnt signaling.

    1. Developmental Biology
    Dena Goldblatt, Basak Rosti ... David Schoppik
    Research Article

    Sensorimotor reflex circuits engage distinct neuronal subtypes, defined by precise connectivity, to transform sensation into compensatory behavior. Whether and how motor neuron populations specify the subtype fate and/or sensory connectivity of their pre-motor partners remains controversial. Here, we discovered that motor neurons are dispensable for proper connectivity in the vestibular reflex circuit that stabilizes gaze. We first measured activity following vestibular sensation in pre-motor projection neurons after constitutive loss of their extraocular motor neuron partners. We observed normal responses and topography indicative of unchanged functional connectivity between sensory neurons and projection neurons. Next, we show that projection neurons remain anatomically and molecularly poised to connect appropriately with their downstream partners. Lastly, we show that the transcriptional signatures that typify projection neurons develop independently of motor partners. Our findings comprehensively overturn a long-standing model: that connectivity in the circuit for gaze stabilization is retrogradely determined by motor partner-derived signals. By defining the contribution of motor neurons to specification of an archetypal sensorimotor circuit, our work speaks to comparable processes in the spinal cord and advances our understanding of principles of neural development.